Bone marrow aspirates as part of routine donor assessment for allogeneic blood and marrow transplantation can reveal presence of occult hematological malignancies in otherwise asymptomatic individuals-Reference-Cited by-同舟云学术

Bone marrow aspirates as part of routine donor assessment for allogeneic blood and marrow transplantation can reveal presence of occult hematological malignancies in otherwise asymptomatic individuals

Published:2004-03-01 Issue:8 Volume:33 Page:855-858
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Kiss T L,Chang H,Daly A,Messner H A,Jamal N,Spaner D,Rubin S,Lipton J H

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1704430.pdf

Reference12 articles.

1. Buckner CD, Clift RA, Sanders JE et al. Marrow harvesting from normal donors. Blood 1984; 64: 630–634.

2. Horowitz MM, Loberiza FR, Bredeson C et al. Transplant registries: guiding clinical decisions and improving outcomes. Oncology 2001; 15: 649–659.

3. Messner HA, Jamal N . Cell culture assessment of hematopoietic progenitors in bone marrow transplantation. J Hematother 1993; 2: 19–25.

4. Messner HA, Curtis JE, Minden MD et al. Clonogenic hemopoietic precursors in bone marrow transplantation. Blood 1987; 70: 1425–1432.

5. Bahn AK . Difference between two independent sample means. In: Basic Medical Statistics. Grune & Stratton Inc.: NewYork, 1972, pp 136–143.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Findings of Potential Donor Origin following Hematopoietic Cell Transplantation: Recommendations on Donor Disclosure and Genetic Testing from the World Marrow Donor Association;Transplantation and Cellular Therapy;2024-02

2. Systematic Scoping Review of Studies Reporting Unexpected Donor-Derived Abnormalities from Recipients of Allogeneic Hematopoietic Cell Transplantation: A Proposed Framework for Donor Disclosure;Transplantation and Cellular Therapy;2022-07

3. Clonal Hematopoiesis in Related Allogeneic Transplant Donors: Implications for Screening and Management;Biology of Blood and Marrow Transplantation;2020-06

4. Influence of the degree of donor bone marrow hyperplasia on patient clinical outcomes after allogeneic hematopoietic stem cell transplantation;Science China Life Sciences;2019-08-13

5. Inversion 3 Cytogenetic Abnormality in an Allogeneic Hematopoietic Cell Transplant Recipient Representative of a Donor-Derived Constitutional Abnormality;Biology of Blood and Marrow Transplantation;2017-09